- Home
- PPSI vs SLGL Comparison
PPSI vs SLGL Comparison
Compare PPSI & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPSI
- SLGL
- Stock Information
- Founded
- PPSI 2008
- SLGL 1997
- Country
- PPSI United States
- SLGL Israel
- Employees
- PPSI N/A
- SLGL 34
- Industry
- PPSI Electrical Products
- SLGL Biotechnology: Pharmaceutical Preparations
- Sector
- PPSI Industrials
- SLGL Health Care
- Exchange
- PPSI Nasdaq
- SLGL Nasdaq
- Market Cap
- PPSI 46.6M
- SLGL 69.1M
- IPO Year
- PPSI N/A
- SLGL 2018
- Fundamental
- Price
- PPSI $4.53
- SLGL $24.75
- Analyst Decision
- PPSI Strong Buy
- SLGL
- Analyst Count
- PPSI 1
- SLGL 0
- Target Price
- PPSI $12.00
- SLGL N/A
- AVG Volume (30 Days)
- PPSI 5.2M
- SLGL 33.4K
- Earning Date
- PPSI 11-13-2025
- SLGL 11-14-2025
- Dividend Yield
- PPSI 33.11%
- SLGL N/A
- EPS Growth
- PPSI N/A
- SLGL N/A
- EPS
- PPSI 2.91
- SLGL N/A
- Revenue
- PPSI $31,279,000.00
- SLGL $23,931,000.00
- Revenue This Year
- PPSI $27.32
- SLGL N/A
- Revenue Next Year
- PPSI $16.14
- SLGL $31.17
- P/E Ratio
- PPSI $1.53
- SLGL N/A
- Revenue Growth
- PPSI 105.82
- SLGL 264.86
- 52 Week Low
- PPSI $2.25
- SLGL $4.01
- 52 Week High
- PPSI $7.00
- SLGL $30.00
- Technical
- Relative Strength Index (RSI)
- PPSI 68.06
- SLGL 61.58
- Support Level
- PPSI $3.65
- SLGL $23.13
- Resistance Level
- PPSI $3.97
- SLGL $30.00
- Average True Range (ATR)
- PPSI 0.27
- SLGL 2.64
- MACD
- PPSI 0.06
- SLGL -0.31
- Stochastic Oscillator
- PPSI 92.56
- SLGL 47.12
About PPSI Pioneer Power Solutions Inc.
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.